Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Toxicol Lett ; 213(2): 135-41, 2012 Sep 03.
Artigo em Inglês | MEDLINE | ID: mdl-22750881

RESUMO

A high-fat (HF) diet, the serotonergic system and stromal elements have all been implicated in colon carcinogenesis. We investigated whether the colonic serotonergic system could play a main role in the development of colonic dysplasia and stromal reactivity in carcinogen-treated rats under HF diet. For this, dimethylhydrazine-treated rats were fed with standard diet and a HF diet. Fat distribution was quantified by computerized tomography exam, serotonergic activity was analyzed by high-performance liquid chromatography, gene expression, and immunohistochemistry, which along with histopathological technique enabled us to enumerate dysplasia, microvessels density, cell proliferation and COX-2 expression. We found that the HF diet induced an increase in the amount of visceral adipose tissue, even without expressive changes in the average body weight. This was correlated with a loss of serotonergic balance in colon tissue. Moreover, the HF diet promoted dysplasia and microvessel density in association with increased proliferation and COX-2 expression within pericryptal colonic stroma. Our current findings suggest that a HF diet promotes the enlargement of adipose tissue via loss of control in colon serotonergic activity, which enhances colonic dysplasia by supporting microvessel development.


Assuntos
Neoplasias do Colo/metabolismo , Neoplasias do Colo/patologia , Dieta Hiperlipídica/efeitos adversos , Gordura Intra-Abdominal/metabolismo , Gordura Intra-Abdominal/patologia , Serotonina/metabolismo , Animais , Ciclo-Oxigenase 2/metabolismo , Gorduras na Dieta/administração & dosagem , Feminino , Ácido Hidroxi-Indolacético/metabolismo , Imuno-Histoquímica , Gordura Intra-Abdominal/enzimologia , Masculino , RNA/química , RNA/genética , Distribuição Aleatória , Ratos , Ratos Wistar , Reação em Cadeia da Polimerase em Tempo Real
2.
Toxicol Lett ; 204(2-3): 134-40, 2011 Jul 28.
Artigo em Inglês | MEDLINE | ID: mdl-21554931

RESUMO

Fluoxetine (FLX) is a drug commonly used as antidepressant. However, its effects on tumorigenesis remain controversial. Aiming to evaluate the effects of FLX treatment on early malignant changes, we analyzed serotonin (5-HT) metabolism and recognition, aberrant crypt foci (ACF), proliferative process, microvessels, vascular endothelial growth factor (VEGF), and cyclooxygenase-2 (COX-2) expression in colon tissue. Male Wistar rats received a daily FLX-gavage (30mgkg(-1)) and, a single dose of 1,2 dimethylhydrazine (DMH; i.p., 125mgkg(-1)). After 6 weeks of FLX-treatment, our results revealed that FLX and nor-fluoxetine (N-FLX) are present in colon tissue, which was related to significant increase in serotonin (5-HT) levels (P<0.05) possibly through a blockade in SERT mRNA (serotonin reuptake transporter; P<0.05) resulting in lower 5-hydroxyindoleacetic acid (5-HIAA) levels (P<0.01) and, 5-HT2C receptor mRNA expressions. FLX-treatment decreased dysplastic ACF development (P<0.01) and proliferative process (P<0.001) in epithelia. We observed a significant decrease in the development of malignant microvessels (P<0.05), VEGF (P<0.001), and COX-2 expression (P<0.01). These findings suggest that FLX may have oncostatic effects on carcinogenic colon tissue, probably due to its modulatory activity on 5-HT metabolism and/or its ability to reduce colonic malignant events.


Assuntos
Neoplasias do Colo/prevenção & controle , Fluoxetina/farmacologia , Inibidores Seletivos de Recaptação de Serotonina/farmacologia , Animais , Proliferação de Células , Colo/efeitos dos fármacos , Colo/metabolismo , Ciclo-Oxigenase 2/análise , Masculino , Lesões Pré-Cancerosas/prevenção & controle , Ratos , Ratos Wistar , Serotonina/metabolismo , Fator A de Crescimento do Endotélio Vascular/análise
3.
Biochem Biophys Res Commun ; 405(4): 593-8, 2011 Feb 25.
Artigo em Inglês | MEDLINE | ID: mdl-21266165

RESUMO

Constant light (LL) is associated with high incidence of colon cancer. MLT supplementation was related to the significant control of preneoplastic patterns. We sought to analyze preneoplastic patterns in colon tissue from animals exposed to LL environment (14 days; 300 lx), MLT-supplementation (10mg/kg/day) and DMH-treatment (1,2 dimethylhydrazine; 125 mg/kg). Rodents were sacrificed and MLT serum levels were measured by radioimmunoassay. Our results indicated that LL induced ACF development (p < 0.001) with a great potential to increase the number of CD133(+) and CD68(+) cells (p < 0.05 and p < 0.001). LL also increased the proliferative process (PCNA-Li; p < 0.001) as well as decreased caspase-3 protein (p < 0.001), related to higher COX-2 protein expression (p < 0.001) within pericryptal colonic stroma (PCCS). However, MLT-supplementation controlled the development of dysplastic ACF (p < 0.001) diminishing preneoplastic patterns into PCCS as CD133 and CD68 (p < 0.05 and p < 0.001). These events were relative to decreased PCNA-Li index and higher expression of caspase-3 protein. Thus, MLT showed a great potential to control the preneoplastic patterns induced by LL.


Assuntos
Neoplasias do Colo/etiologia , Neoplasias do Colo/prevenção & controle , Luz/efeitos adversos , Melatonina/administração & dosagem , Células-Tronco Neoplásicas/efeitos dos fármacos , Animais , Colo/efeitos dos fármacos , Colo/metabolismo , Colo/patologia , Colo/efeitos da radiação , Neoplasias do Colo/patologia , Masculino , Melatonina/sangue , Melatonina/fisiologia , Células-Tronco Neoplásicas/metabolismo , Células-Tronco Neoplásicas/patologia , Ratos , Ratos Wistar , Células Estromais/efeitos dos fármacos , Células Estromais/metabolismo , Células Estromais/patologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...